TLR4 and breast cancer: Brown (42) reviewed that NF-κB pathway activation upregulates TGM2 level in the breast cancer, and Kiziltas (34) reported that NF-κB pathway activation is the common downstream pathway of TLR4 signal pathway activation in the liver.